MGMT and astrocytoma (excluding glioblastoma): Differentiating MGMT methylated astrocytomas early on is especially important for identifying tumor susceptibility to temozolomide chemotherapy treatment as well as predicting the efficacy of Carmustine wafer implantation [49,50].